Skip to content
Parker Institute for Cancer Immunotherapy
Search Close

Fred Hutchinson Cancer Center

Philip Greenberg is developing powerful T-cells that target cancer

Fred Hutchinson Cancer Center is at the forefront of a fundamental shift in how cancer is treated and cured. At Fred Hutch, PICI researcher Philip Greenberg, MD, develops new ways to empower a patient’s immune system to eradicate cancer. With PICI, he uses mouse models to characterize and test translatable strategies to treat many cancers. He also develops more effective T-cells to treat ovarian cancer through adoptive cell therapy. Tijana Martinov, PhD, a Parker Scholar in Greenberg’s lab, designs and tests T-cells that target and destroy multiple myeloma in mouse models.

Philip Greenberg, MD | Investigator
Tijana Martinov, PhD | Parker Scholar